Phase 1b clinical trial evaluating BL-001 in adults with obesity
Latest Information Update: 05 Mar 2026
At a glance
- Drugs BL-001 (Primary)
- Indications Obesity
- Focus Adverse reactions
Most Recent Events
- 05 Mar 2026 New trial record
- 24 Feb 2026 According to Bloom Science media release, company announced that the first patient has been dosed in this study.